Global Respiratory Disease Vaccine Market | Market Research Report

The Global Respiratory Disease Vaccine Market to grow from USD 18,236.13 Million in 2018 to USD 25,236.13 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.75%. Some of the major market players include AstraZeneca, Bavarian Nordic, Dynavax Technologies Corporation, Emergent BioSolutions, Inc., and GlaxoSmithKline plc.

360iResearch Logo
Global Respiratory Disease Vaccine Market
Report Code: MRR-9C0DAB1 | Publishing Date: | Number of Pages: 155
Global Respiratory Disease Vaccine Market | Market Research Report

Market Dynamics:

The factors attributing to the growth of the market are clinical trials and vaccines developments in pipeline, increasing prevalence of respiratory disorders, and government initiatives supporting respiratory health . However, some factors such as lack of inadequate delivery infrastructure & limited awareness may hinder the market growth. The Respiratory Disease Vaccine Market is expected to showcase the opportunities such as increasing r&d expenditure by leading companies and increase vaccine availability through reselling collaborations . In the near future market may face the possible challenges in the growth due to consumer trust & confidence in respiratory disease vaccination. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Respiratory Disease Vaccine Market.

Global Respiratory Disease Vaccine Market: Market Dynamics
Global Respiratory Disease Vaccine Market: Market Dynamics

Market Segmentation & Coverage:

The research report categorizes the Respiratory Disease Vaccine Market to forecast the revenues and analyze the trends in each of the following segments:

On the basis of Infection, the Respiratory Disease Vaccine Market is studied across Influenza Virus, Pertussis, Streptococcus Pneumoniae, and Tuberculosis. The Influenza Virus commanded the largest size in the Respiratory Disease Vaccine Market in 2018, followed by the Tuberculosis. On the other hand, the Streptococcus Pneumoniae is expected to grow at the fastest CAGR during the forecast period, followed by the Tuberculosis.

On the basis of Type, the Respiratory Disease Vaccine Market is studied across Bacterial Vaccine, Combination Vaccine, and Viral Vaccine. The Viral Vaccine commanded the largest size in the Respiratory Disease Vaccine Market in 2018, followed by the Bacterial Vaccine. On the other hand, the Combination Vaccine is expected to grow at the fastest CAGR during the forecast period, followed by the Viral Vaccine.

On the basis of Age Group, the Respiratory Disease Vaccine Market is studied across Adolescent Vaccination, Adult Vaccination, and Infant Vaccination. The Infant Vaccination commanded the largest size in the Respiratory Disease Vaccine Market in 2018, followed by the Adolescent Vaccination. On the other hand, the Adult Vaccination is expected to grow at the fastest CAGR during the forecast period, followed by the Infant Vaccination.

On the basis of Geography, the Respiratory Disease Vaccine Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas commanded the largest size in the Respiratory Disease Vaccine Market in 2018, followed by the Europe, Middle East & Africa. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period, followed by the Europe, Middle East & Africa.

Competitive News Feed Analysis:

The research report closely tracks the resent developments by the dominating players and innovation profiles in the market including:

  • Pfizer says antiviral compounds against coronavirus identified (2020-03-03)
  • Ministry of SOEs asks Bio Farma to produce coronavirus vaccine (2020-03-03)
  • Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine (2020-03-02)

Company Usability Profiles:

The Respiratory Disease Vaccine Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The Respiratory Disease Vaccine Market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • AstraZeneca
  • Bavarian Nordic
  • Dynavax Technologies Corporation
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus USA Inc.
  • Serum institute of India Private Limited
  • Bayer AG
  • Bio Farma

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Respiratory Disease Vaccine Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Respiratory Disease Vaccine Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Respiratory Disease Vaccine Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Respiratory Disease Vaccine Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Respiratory Disease Vaccine Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Respiratory Disease Vaccine Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Respiratory Disease Vaccine Market .
  • Evaluate the key vendors in the Respiratory Disease Vaccine Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Geography Outlook
    3. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Respiratory Disease Vaccine Market, By Geography
    3. Respiratory Disease Vaccine Market, By Infection
    4. Respiratory Disease Vaccine Market, By Type
    5. Respiratory Disease Vaccine Market, By Age Group
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increasing prevalence of respiratory disorders
      2. Clinical trials and vaccines developments in pipeline
      3. Government initiatives supporting respiratory health
    3. Restraints
      1. Lack of inadequate delivery infrastructure & limited awareness
    4. Opportunities
      1. Increasing R&D expenditure by leading companies
      2. Increase vaccine availability through reselling collaborations
    5. Challenges
      1. Consumer trust & confidence in respiratory disease vaccination
  6. Industry Trends
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Client Customizations
      1. COVID: Eye on Proactive Vaccine Development
  7. Respiratory Disease Vaccine Market, By Infection
    1. Introduction
    2. Influenza Virus
    3. Pertussis
    4. Streptococcus Pneumoniae
    5. Tuberculosis
  8. Respiratory Disease Vaccine Market, By Type
    1. Introduction
    2. Bacterial Vaccine
    3. Combination Vaccine
    4. Viral Vaccine
  9. Respiratory Disease Vaccine Market, By Age Group
    1. Introduction
    2. Adolescent Vaccination
    3. Adult Vaccination
    4. Infant Vaccination
  10. Respiratory Disease Vaccine Market, By Americas
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Respiratory Disease Vaccine Market, By Asia-Pacific
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  12. Respiratory Disease Vaccine Market, By Europe, Middle East & Africa
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  13. Competitive Landscape
    1. FPNV Positioning Matrix
    2. Market Vendor Ranking Analysis
    3. Competitive News Feed Analysis
  14. Company Usability Profiles
    1. AstraZeneca
      1. Overview
      2. Key Takeaways
      3. Recommendations
    2. Bavarian Nordic
      1. Overview
      2. Key Takeaways
      3. Recommendations
    3. Dynavax Technologies Corporation
      1. Overview
      2. Key Takeaways
      3. Recommendations
    4. Emergent BioSolutions, Inc.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    5. GlaxoSmithKline plc
      1. Overview
      2. Key Takeaways
      3. Recommendations
    6. Merck & Co., Inc.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    7. Pfizer Inc.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    8. Sanofi S.A.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    9. Seqirus USA Inc.
      1. Overview
      2. Key Takeaways
      3. Recommendations
    10. Serum institute of India Private Limited
      1. Overview
      2. Key Takeaways
      3. Recommendations
    11. Bayer AG
      1. Overview
      2. Key Takeaways
      3. Recommendations
    12. Bio Farma
      1. Overview
      2. Key Takeaways
      3. Recommendations
  15. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2016-2025 (USD MILLION)
  3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFLUENZA VIRUS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PERTUSSIS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STREPTOCOCCUS PNEUMONIAE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TUBERCULOSIS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY BACTERIAL VACCINE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COMBINATION VACCINE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  11. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VACCINE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT VACCINATION, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT VACCINATION, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  16. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  17. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  18. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  19. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  20. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  21. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  22. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  23. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  24. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  25. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  26. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  27. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  28. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  29. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  30. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  31. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  32. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  33. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  34. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  35. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  36. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  37. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  38. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  39. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  40. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  41. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  42. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  43. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  44. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  45. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  46. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  47. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  48. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  49. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  50. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  51. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  52. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  53. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  54. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  55. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  56. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  57. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  58. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  59. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  60. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  61. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  62. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  63. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  64. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  65. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  66. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  67. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  68. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  69. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  70. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  71. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  72. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  73. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  74. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  75. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  76. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  77. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  78. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  79. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  80. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  81. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  82. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  83. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  84. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  85. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  86. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  87. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  88. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  89. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  90. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  91. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  92. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  93. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  94. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  95. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  96. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  97. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  98. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  99. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  100. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2016-2025 (USD MILLION)
  101. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  102. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2016-2025 (USD MILLION)
  103. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RANKING
  104. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: BUSINESS STRATEGY
  105. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: PRODUCT SATISFACTION
  106. COMPETITIVE NEWS FEED ANALYSIS FOR ASTRAZENECA
  107. COMPETITIVE NEWS FEED ANALYSIS FOR BAVARIAN NORDIC
  108. COMPETITIVE NEWS FEED ANALYSIS FOR DYNAVAX TECHNOLOGIES CORPORATION
  109. COMPETITIVE NEWS FEED ANALYSIS FOR EMERGENT BIOSOLUTIONS, INC.
  110. COMPETITIVE NEWS FEED ANALYSIS FOR GLAXOSMITHKLINE PLC
  111. COMPETITIVE NEWS FEED ANALYSIS FOR MERCK & CO., INC.
  112. COMPETITIVE NEWS FEED ANALYSIS FOR PFIZER INC.
  113. COMPETITIVE NEWS FEED ANALYSIS FOR SANOFI S.A.
  114. COMPETITIVE NEWS FEED ANALYSIS FOR SEQIRUS USA INC.
  115. COMPETITIVE NEWS FEED ANALYSIS FOR SERUM INSTITUTE OF INDIA PRIVATE LIMITED
  116. COMPETITIVE NEWS FEED ANALYSIS FOR BAYER AG
  117. COMPETITIVE NEWS FEED ANALYSIS FOR BIO FARMA
  118. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: EDITION DETAILS
  119. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: LICENSE DETAILS
  120. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RESEARCH PROCESS
  2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: RESEARCH FRAMEWORK
  3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: FORECASTING METHODOLOGY
  4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  5. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY NEWS TYPE
  6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2016-2025 (USD MILLION)
  7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018 VS 2025 (USD MILLION)
  8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018 VS 2025 (USD MILLION)
  9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018 VS 2025 (USD MILLION)
  10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018 VS 2025 (USD MILLION)
  11. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: MARKET DYNAMICS
  12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2025 (USD MILLION)
  14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY INFLUENZA VIRUS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY PERTUSSIS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  16. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY STREPTOCOCCUS PNEUMONIAE SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  17. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY TUBERCULOSIS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2025 (USD MILLION)
  19. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY BACTERIAL VACCINE SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  20. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY COMBINATION VACCINE SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  21. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY VIRAL VACCINE SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025 (USD MILLION)
  23. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY ADOLESCENT VACCINATION SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  24. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY ADULT VACCINATION SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  25. GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY INFANT VACCINATION SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  26. GLOBAL RESPIRATORY DISEASE VACCINE MARKET: FPNV POSITIONING MATRIX
  27. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY COMPANY
  28. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL RESPIRATORY DISEASE VACCINE MARKET, BY YEAR
  1. AstraZeneca
  2. Bavarian Nordic
  3. Dynavax Technologies Corporation
  4. Emergent BioSolutions, Inc.
  5. GlaxoSmithKline plc
  6. Merck & Co., Inc.
  7. Pfizer Inc.
  8. Sanofi S.A.
  9. Seqirus USA Inc.
  10. Serum institute of India Private Limited
  11. Bayer AG
  12. Bio Farma
Global Respiratory Disease Vaccine Market
Report Code
MRR-9C0DAB1
Publishing Date
March 2020
Number of Pages
155
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $9449
CORPORATE USER LICENSE $7449
SINGLE USER LICENSE $5449

Trusted by 2,000+ Companies Worldwide

Here's what some of our customers say about our work.
We appreciate all of our customers' testimonials.